These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31371146)

  • 21. Gene therapy corrects the neurological deficits of mice with sialidosis.
    Hwu WL; Chang K; Liu YH; Wang HC; Lee NC; Chien YH
    Gene Ther; 2024 May; 31(5-6):263-272. PubMed ID: 38321198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sialidosis type I presenting with a novel mutation and advanced neuroimaging features.
    Gultekin M; Bayramov R; Karaca C; Acer N
    Neurosciences (Riyadh); 2018 Jan; 23(1):57-61. PubMed ID: 29455223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement.
    Mohammad AN; Bruno KA; Hines S; Atwal PS
    Mol Genet Metab Rep; 2018 Jun; 15():11-14. PubMed ID: 30023283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Looking "Cherry Red Spot Myoclonus" in the Eyes: Clinical Phenotype, Treatment Response, and Eye Movements in Sialidosis Type 1.
    Riboldi GM; Martone J; Rizzo JR; Hudson TE; Rucker JC; Frucht SJ
    Tremor Other Hyperkinet Mov (N Y); 2021; 11():53. PubMed ID: 34992946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel spot mutation leading to sialidosis type 1-myoclonus syndrome and optical coherence tomography findings.
    Meşen S; Batur M; Ozer MD
    Arq Bras Oftalmol; 2023; 87(5):e20220069. PubMed ID: 39298726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex.
    Lukong KE; Landry K; Elsliger MA; Chang Y; Lefrancois S; Morales CR; Pshezhetsky AV
    J Biol Chem; 2001 May; 276(20):17286-90. PubMed ID: 11279074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient.
    Penzel R; Uhl J; Kopitz J; Beck M; Otto HF; Cantz M
    FEBS Lett; 2001 Jul; 501(2-3):135-8. PubMed ID: 11470272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variable phenotype and severity of sialidosis expressed in two siblings presenting with ataxia and macular cherry-red spots.
    Vieira de Rezende Pinto WB; Sgobbi de Souza PV; Pedroso JL; Barsottini OG
    J Clin Neurosci; 2013 Sep; 20(9):1327-8. PubMed ID: 23870618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation.
    Liu SP; Hsu YH; Huang CY; Ho MC; Cheng YC; Wen CH; Lu HE; Tsai CH; Shyu WC; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():39-43. PubMed ID: 29414417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase.
    Loren DJ; Campos Y; d'Azzo A; Wyble L; Grange DK; Gilbert-Barness E; White FV; Hamvas A
    J Perinatol; 2005 Jul; 25(7):491-4. PubMed ID: 15908988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
    Kwak JE; Son MY; Son YS; Son MJ; Cho YS
    Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype correlation and founder effect analysis in southeast Chinese patients with sialidosis type I.
    Du YC; Ma LH; Li QF; Ma Y; Dong Y; Wu ZY
    Orphanet J Rare Dis; 2024 Sep; 19(1):362. PubMed ID: 39350194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients.
    Caciotti A; Di Rocco M; Filocamo M; Grossi S; Traverso F; d'Azzo A; Cavicchi C; Messeri A; Guerrini R; Zammarchi E; Donati MA; Morrone A
    J Neurol; 2009 Nov; 256(11):1911-5. PubMed ID: 19568825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.
    Bonten EJ; Yogalingam G; Hu H; Gomero E; van de Vlekkert D; d'Azzo A
    Biochim Biophys Acta; 2013 Oct; 1832(10):1784-92. PubMed ID: 23770387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression.
    Pattison S; Pankarican M; Rupar CA; Graham FL; Igdoura SA
    Hum Mutat; 2004 Jan; 23(1):32-9. PubMed ID: 14695530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations.
    Han MJ; Annunziata I; Weesner J; Campos Y; Salie M; O'Reilly C; d'Azzo A
    Stem Cell Res; 2020 Jul; 46():101836. PubMed ID: 32485644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient.
    Uhl J; Penzel R; Sergi C; Kopitz J; Otto HF; Cantz M
    FEBS Lett; 2002 Jun; 521(1-3):19-23. PubMed ID: 12067718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Child Neurology: Type 1 sialidosis due to a novel mutation in
    Aravindhan A; Veerapandiyan A; Earley C; Thulasi V; Kresge C; Kornitzer J
    Neurology; 2018 Mar; 90(13):622-624. PubMed ID: 29581327
    [No Abstract]   [Full Text] [Related]  

  • 39. Sialidosis Type I without a Cherry Red Spot- Is There a Genetic Basis?
    Neeraja K; Holla VV; Prasad S; Surisetti BK; Rakesh K; Kamble N; Yadav R; Pal PK
    J Mov Disord; 2021 Jan; 14(1):65-69. PubMed ID: 33121223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement.
    Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K
    Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.